Beloranib (hemioxalate)
Beloranib (ZGN-440; ZGN-433) hemioxalate is a fumagillin-class methionine aminopetidase-2 (MetAP2) inhibitor. Beloranib hemioxalate decreases food intake, body weight, fat mass, and the size of adipocytes. Beloranib hemioxalate plays an important role in anti-obesity activity or obesity research[1][2][3][4].
Product Specifications
CAS Number
529511-79-3
Product Name Alternative
ZGN-440 (hemioxalate) ; ZGN-433 (hemioxalate) ; CDK732 (hemioxalate)
UNSPSC
12352005
Target
MetAP
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/beloranib-hemioxalate.html
Smiles
C[C@]1([C@H](O1)C/C=C(C)\C)[C@]2([H])[C@]3(CC[C@H]([C@H]2OC)OC(/C=C/C4=CC=C(C=C4)OCCN(C)C)=O)CO3.O=C(O)C(O)=O.[0.5]
Molecular Formula
C29H41NO6.1/2C2H2O4
Molecular Weight
1089.32
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 3
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD50 (ICAM-3) (186-2G9), CF594 conjugate, 0.1mg/mL
ACTH (Adrenocorticotrophic Hormone) (AH26), CF594 conjugate, 0.1mg/mL
Major Vault Protein (MVP) (1032), CF594 conjugate, 0.1mg/mL
